Skip to main content
. 2021 Sep 3;12:723172. doi: 10.3389/fimmu.2021.723172

Figure 6.

Figure 6

Overview of the study design. (A) Clustering analysis of METcor/CNVcor gene sets by NMF. (B) Identification and analysis of molecular subtypes. (C) Signatures of molecular subtypes built the prognostic risk model, which was validated in multiple cohorts. (D) Distinct TIME of risk subgroups was validated by IHC.